Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study (NCT07114718)
🩺 Plain-English Summary (8th-Grade Level)
Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.
Who can join: Review the eligibility criteria below.
Location: UCLA Mattel Children's — Los Angeles, California
Age range: 1 Minute to 6 Months
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- UCLA Mattel Children's — Los Angeles, California
- Leland Stanford Junior University — Stanford, California
- Children's Hospital Colorado — Aurora, Colorado
- Boston Children's Hospital — Boston, Massachusetts
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
- Nationwide Children's Hospital — Columbus, Ohio
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
- Texas Children's Hospital - Baylor College of Medicine — Houston, Texas
- Seattle Children's Hospital — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (734) 709-2080
Email: marybeth.tate@globalmedicaldeviceconsultants.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Congenital Heart Disease
- Technical Development for Pediatric Cardiovascular MRI — Washington D.C., District of Columbia
- Harmony TPV Post-Approval Study — Birmingham, Alabama
- The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study — Los Angeles, California
- Autus Valve Pivotal Study — Los Angeles, California
- Peer Coaching Intervention in Young Adults With Congenital Heart Disease — Durham, North Carolina
- SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure — Toronto, Ontario
Explore by condition: All Congenital Heart Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.